James Turkson

18.9k total citations · 9 hit papers
109 papers, 15.5k citations indexed

About

James Turkson is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, James Turkson has authored 109 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Oncology, 62 papers in Molecular Biology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in James Turkson's work include Cytokine Signaling Pathways and Interactions (69 papers), PI3K/AKT/mTOR signaling in cancer (30 papers) and Cancer Mechanisms and Therapy (20 papers). James Turkson is often cited by papers focused on Cytokine Signaling Pathways and Interactions (69 papers), PI3K/AKT/mTOR signaling in cancer (30 papers) and Cancer Mechanisms and Therapy (20 papers). James Turkson collaborates with scholars based in United States, Canada and Argentina. James Turkson's co-authors include Richard Jove, Tammy Bowman, Roy Garcia, Khandaker Siddiquee, Peibin Yue, Eric B. Haura, Saı̈d M. Sebti, Shumin Zhang, James G. Karras and Robyn Catlett-Falcone and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

James Turkson

106 papers receiving 15.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STATs in oncogenesis

2000 1.5k citations Tammy Bowman, James Turkson et al. Oncogene profile →
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

1999 1.4k citations Robyn Catlett-Falcone, Marc M. Oshiro et al. profile →
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

2002 1.0k citations Guilian Niu, Kenneth L. Wright et al. Oncogene profile →
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

2007 616 citations Shumin Zhang, Richard Jove et al. profile →
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation

1998 583 citations James Turkson, Tammy Bowman et al. Molecular and Cellular Biology profile →
STAT proteins: novel molecular targets for cancer drug discovery

2000 541 citations James Turkson, Richard Jove Oncogene profile →
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

2001 505 citations Pearlie K. Epling‐Burnette, Jin Hong Liu et al. Journal of Clinical Investigation profile →
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

2005 489 citations Qing Xu, Sungman Park et al. Oncogene profile →
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

2022 323 citations Peibin Yue, James Turkson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Turkson United States	47	9.5k	7.9k	3.2k	2.9k	2.5k	109	15.5k
Jacqueline Bromberg United States	44	8.6k 0.9×	6.6k 0.8×	3.6k 1.1×	2.0k 0.7×	2.8k 1.1×	83	13.5k
Saı̈d M. Sebti United States	73	6.7k 0.7×	11.0k 1.4×	2.1k 0.7×	1.4k 0.5×	2.0k 0.8×	250	16.7k
Hua Yu United States	69	14.0k 1.5×	11.7k 1.5×	9.5k 3.0×	3.4k 1.2×	5.0k 2.0×	170	26.0k
Paul Dent United States	81	7.0k 0.7×	15.6k 2.0×	2.1k 0.7×	1.5k 0.5×	2.4k 1.0×	388	23.1k
Steven Grant United States	79	6.3k 0.7×	16.7k 2.1×	2.2k 0.7×	1.6k 0.6×	2.3k 0.9×	451	23.2k
Eric B. Haura United States	63	7.0k 0.7×	8.8k 1.1×	1.9k 0.6×	1.4k 0.5×	2.8k 1.1×	278	14.7k
Zhiwei Wang China	65	4.4k 0.5×	8.8k 1.1×	1.2k 0.4×	1.0k 0.4×	3.4k 1.4×	250	13.6k
Robert L. Sutherland Australia	78	7.8k 0.8×	10.4k 1.3×	1.5k 0.5×	1.2k 0.4×	3.8k 1.5×	236	19.2k
Jiayuh Lin United States	55	5.3k 0.6×	4.9k 0.6×	1.2k 0.4×	1.3k 0.4×	1.3k 0.5×	137	8.6k
Antonio Tito Fojo United States	48	8.4k 0.9×	6.9k 0.9×	802 0.3×	1.1k 0.4×	1.5k 0.6×	137	13.6k

Countries citing papers authored by James Turkson

Since Specialization

Citations

This map shows the geographic impact of James Turkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Turkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Turkson more than expected).

Fields of papers citing papers by James Turkson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Turkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Turkson. The network helps show where James Turkson may publish in the future.

Co-authorship network of co-authors of James Turkson

This figure shows the co-authorship network connecting the top 25 collaborators of James Turkson. A scholar is included among the top collaborators of James Turkson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Turkson. James Turkson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dambal, Shweta, Mahmoud A. Alfaqih, Adela Ramírez‐Torres, et al.. (2020). 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells. Molecular Cancer Research. 18(5). 671–684. 44 indexed citations

Graham, James M., Katrin P. Guillen, Patsy G. Oliver, et al.. (2020). STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer. Cancer Research. 80(20). 4355–4370. 22 indexed citations

Hilliard, Tyvette S., et al.. (2017). 15α-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models. Molecular Cancer Therapeutics. 16(4). 601–613. 12 indexed citations

Ma, Chi, Manoj Nepal, Yihang Shen, et al.. (2017). Involvement of FANCD2 in Energy Metabolism via ATP5α. Scientific Reports. 7(1). 4921–4921. 20 indexed citations

Li, Chun‐Shun, Baojun Yang, James Turkson, & Shugeng Cao. (2017). Anti-proliferative ambuic acid derivatives from Hawaiian endophytic fungus Pestalotiopsis sp. FT172. Phytochemistry. 140. 77–82. 27 indexed citations

Cai, You‐Sheng, Ariel M. Sarotti, Daniela Gündisch, et al.. (2017). Heliotropiumides A and B, new phenolamides with N-carbamoyl putrescine moiety from Heliotropium foertherianum collected in Hawaii and their biological activities. Bioorganic & Medicinal Chemistry Letters. 27(20). 4630–4634. 4 indexed citations

Yue, Peibin, David Paladino, Yifei Li, et al.. (2015). Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo. Cancer Research. 76(3). 652–663. 60 indexed citations

Mitra, Rajendra Narayan, Xiaolei Zhang, Niclas E. Bengtsson, et al.. (2011). An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials. 33(5). 1500–1508. 48 indexed citations

Barbieri, Isaia, Sara Pensa, Tania Pannellini, et al.. (2010). Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten. Cancer Research. 70(6). 2558–2567. 124 indexed citations

10.

Yue, Peibin, et al.. (2010). Enhanced Sensitivity of Pancreatic Cancer Cells to Concurrent Inhibition of Aberrant Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor or Src. Journal of Pharmacology and Experimental Therapeutics. 333(2). 373–381. 28 indexed citations

11.

Zhao, Wei, et al.. (2010). A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro. Journal of Biological Chemistry. 285(46). 35855–35865. 52 indexed citations

12.

Fletcher, Steven, Xiaolei Zhang, Peibin Yue, et al.. (2009). Disruption of Transcriptionally Active Stat3 Dimers with Non‐phosphorylated, Salicylic Acid‐Based Small Molecules: Potent in vitro and Tumor Cell Activities. ChemBioChem. 10(12). 1959–1964. 70 indexed citations

13.

Hillion, Jöelle, Surajit Dhara, Takita Felder Sumter, et al.. (2008). The High-Mobility Group A1a/Signal Transducer and Activator of Transcription-3 Axis: An Achilles Heel for Hematopoietic Malignancies?. Cancer Research. 68(24). 10121–10127. 87 indexed citations

14.

Turkson, James, et al.. (2005). A Novel Platinum Compound Inhibits Constitutive Stat3 Signaling and Induces Cell Cycle Arrest and Apoptosis of Malignant Cells. Journal of Biological Chemistry. 280(38). 32979–32988. 135 indexed citations

15.

Xu, Qing, Sungman Park, Guilian Niu, et al.. (2005). Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 24(36). 5552–5560. 489 indexed citations breakdown →

16.

Vultur, Adina, Jun Cao, Rozanne Arulanandam, et al.. (2004). Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene. 23(15). 2600–2616. 89 indexed citations

17.

Song, Lanxi, James Turkson, James G. Karras, Richard Jove, & Eric B. Haura. (2003). Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene. 22(27). 4150–4165. 315 indexed citations

18.

Niu, Guilian, Kenneth L. Wright, Mei Huang, et al.. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 21(13). 2000–2008. 1019 indexed citations breakdown →

19.

Epling‐Burnette, Pearlie K., Jin Hong Liu, Robyn Catlett-Falcone, et al.. (2001). Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. Journal of Clinical Investigation. 107(3). 351–362. 505 indexed citations breakdown →

20.

Turkson, James, Tammy Bowman, Jalila Adnane, et al.. (1999). Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein. Molecular and Cellular Biology. 19(11). 7519–7528. 226 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact